Price Chart

Profile

bluebird bio Inc is a  biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.
URL https://www.bluebirdbio.com
Investor Relations URL https://investor.bluebirdbio.com
HQ State/Province Massachusetts
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Blend
Next Earnings Release Mar. 29, 2024 (est.)
Last Earnings Release Nov. 07, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A

Profile

bluebird bio Inc is a  biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.
URL https://www.bluebirdbio.com
Investor Relations URL https://investor.bluebirdbio.com
HQ State/Province Massachusetts
Sector Healthcare
Industry Biotechnology
Equity Style Small Cap/Blend
Next Earnings Release Mar. 29, 2024 (est.)
Last Earnings Release Nov. 07, 2023
Next Ex-Dividend Date N/A
Last Ex-Dividend Date N/A